Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Indian J Gastroenterol ; 33(4): 375-82, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24777895

RESUMO

BACKGROUND: This study was conducted to determine characters and risk factors of Helicobacter pylori infection and its relationship with recurrent abdominal pain and other gastrointestinal symptoms at the main children's intermediate school in Rabigh, Saudi Arabia. METHODS: A cross-sectional study was conducted at a boys' intermediate school. A questionnaire for the gastrointestinal (GI) symptoms and relevant personal and socioeconomic risk factors related to H. pylori infection was distributed followed by H. pylori IgG antibody assay and 14C urea breath test to detect active infection. RESULTS: H. pylori was diagnosed by positive urea breath test in 51.5 % of students. H. pylori infection was symptomatic with at least one upper GI symptom in 89.7 % of infected students which was higher than symptomatic cases reported in any other study. H. pylori-infected students had significantly more association with the presence of any upper GI symptom (p < 0.001), recurrent abdominal pain (p < 0.001), anorexia (p < 0.001), nausea (p < 0.026), family history of peptic disease (p < 0.001), drinking desalinated municipal water (p < 0.001), lower income (p = 0.02), and eating outside home (p = 0.003) than uninfected students. Logistic regression analysis showed that the most significant predictors of H. pylori infection were presence of any upper GI symptom (OR 5.3, 95 % CI 2.32-15.71), family history of peptic disease (OR 2.2, 95 % CI 1.11-3.9), and drinking desalinated municipal water (OR 2.1, 95 % CI 1.09-3.2). CONCLUSIONS: This study presented unique features and risk factors of H. pylori infection in 12-15-year-old Saudi boys in Rabigh, and mainly supported the role of H. pylori in causing recurrent abdominal pain.


Assuntos
Dor Abdominal/etiologia , Gastrite/epidemiologia , Gastrite/microbiologia , Infecções por Helicobacter , Helicobacter pylori , Instituições Acadêmicas/estatística & dados numéricos , Adolescente , Anticorpos Antibacterianos/sangue , Biomarcadores/sangue , Testes Respiratórios , Criança , Água Potável , Gastrite/complicações , Gastrite/diagnóstico , Helicobacter pylori/imunologia , Humanos , Imunoglobulina G/sangue , Modelos Logísticos , Masculino , Recidiva , Fatores de Risco , Arábia Saudita/epidemiologia
2.
J Egypt Soc Parasitol ; 43(2): 295-302, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24260808

RESUMO

This study determined the pattern of skin prick test reactivity to allergens in patients with airway allergy residing in Rabigh Area, based on data analysis of skin prick test results. Skin prick tests of 160 Saudi attended Al Nakheel Polyclinic between July, 2012 and April, 2013. Allergen extracts set was used to test them. Out 160 patients, 114 (71%) reacted to one or more allergens, who were 73 (64%) adults and 41(36 %) children. The majority of adults (17.8%) reacted to six allergens and children (19.5%) reacted to five ones. The most frequently reacting allergen was house dust mites followed by Candida albicans then Cladosporium spp. The maximum number of positive tests per patients was 13 in adults, compared to 10 in children. A significantly higher proportion of adults were reacting to house dust mites, Aspergillus and Penicillium. Sensitivity to allergens was common in patients with airway allergy residing in Rabigh area


Assuntos
Alérgenos/imunologia , Hipersensibilidade/imunologia , Adolescente , Adulto , Criança , Feminino , Humanos , Hipersensibilidade/epidemiologia , Masculino , Pessoa de Meia-Idade , Arábia Saudita/epidemiologia , Testes Cutâneos , Adulto Jovem
3.
Indian J Pharmacol ; 45(5): 470-3, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24130381

RESUMO

OBJECTIVES: Helicobacter pylori infection may be associated with low iron stores and iron deficiency anemia. Eradication of infection by the standard 10-day therapy (a proton pump inhibitor [PPI], clarithromycin and amoxicillin; each given orally, twice daily) is decreasing. The sequential 10-day therapy (a PPI and amoxicillin; each given orally twice daily for 5 days; followed by a PPI, clarithromycin and tinidazole; each given orally twice daily for another 5 days) may achieve higher eradication rates. This study was designed to investigate, which eradication regimen; sequential or standard; more effectively improves the associated iron status and iron deficiency in children. MATERIALS AND METHODS: Children (12-15 years) with H. pylori active infection (positive H. pylori immunoglobulin G and urea breath test [UBT]) were subjected to measurement of serum ferritin and then randomized into two groups to receive standard and sequential eradication therapy. Six weeks after completing therapy, UBT was performed to check eradication and serum ferritin was measured to estimate affection by therapy. Statistical Package for Social Sciences (SPSS, IBM, NY, USA) was used for analysis. RESULTS: H. pylori eradication rates of sequential versus standard therapy were non-significantly different. Serum ferritin non-significantly differed between the two therapy groups and in the same group before and after treatment. CONCLUSIONS: There is no significant difference in H. pylori eradication rates between sequential and standard therapies in children. Moreover, no significant relationship was found between eradication therapy and serum ferritin. Further studies enrolling more markers of iron deficiency are required to precisely assess this relationship.


Assuntos
Anemia Ferropriva/complicações , Antibacterianos/administração & dosagem , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/isolamento & purificação , Inibidores da Bomba de Prótons/administração & dosagem , Adolescente , Amoxicilina/administração & dosagem , Amoxicilina/uso terapêutico , Antibacterianos/uso terapêutico , Criança , Claritromicina/administração & dosagem , Claritromicina/uso terapêutico , Esquema de Medicação , Quimioterapia Combinada , Infecções por Helicobacter/complicações , Infecções por Helicobacter/microbiologia , Humanos , Inibidores da Bomba de Prótons/uso terapêutico , Tinidazol/administração & dosagem , Tinidazol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA